SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-028751
Filing Date
2020-12-17
Accepted
2020-12-17 17:14:49
Documents
14
Period of Report
2020-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10018060_8k.htm   iXBRL 8-K 42758
2 EXHIBIT 10.1 brhc10018060_ex10-1.htm EX-10.1 32250
6 image0.jpg GRAPHIC 32875
  Complete submission text file 0001140361-20-028751.txt   304384

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cemi-20201217.xsd EX-101.SCH 4192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20201217_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20201217_pre.xml EX-101.PRE 16214
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10018060_8k_htm.xml XML 4061
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 201397034
SIC: 2834 Pharmaceutical Preparations